A comparative study of inhaled ciclesonide 160 mcg/day vs budesonide 400 mcg/day in patients with asthma

Trial Profile

A comparative study of inhaled ciclesonide 160 mcg/day vs budesonide 400 mcg/day in patients with asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Budesonide; Ciclesonide
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2012 Takeda Global Research and Development Center added as company and lead trial centre as reported by ClinicalTrials.gov.
    • 04 May 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 24 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top